Plasma protein profiling in a stage defined pancreatic cancer cohort – Implications for early diagnosis

Anna Sandström Gerdtsson, Christer Wingren, Helena Persson, Payam Delfani, Malin Nordström, He Ren, Xin Wen, Ulrika Ringdahl, Carl A.K. Borrebaeck, Jihui Hao. Molecular Oncology, 2016

Poster presentation: Early-stage diagnosis of pancreatic cancer offers opportunity to improve patient survival

Linda Mellby, Andreas Holmér, Julia S Johansen, Christer Wingren, Christopher Corless, Brett C Sheppard, Paige Rosenthal, Stig E Bojesen, Breanna L Mitchell, Børge G Nordestgaard, Rosalie Sears, and Carl AK Borrebaeck

IMMray™ PanCan-d poster presentation at the International Symposium on Pancreatic Cancer in Glasgow, UK, June 9-12 2016

Click here to read the complete poster (PDF)

A multicenter trial defining a serum protein signature associated with pancreatic ductal adenocarcinoma

Sandström Gerdtsson A, Malats N, Säll A, Real F, Porta M, Skoog P, Person H, Wingren C, Borrebaeck CAK. Int. J Proteomics. 2015

Serum protein profiling of pancreatitis using recombinant antibody microarrays reveals disease-associated biomarker signatures.

Sandström, A., Andersson, R., Segersvärd, R., Löhr, M., Borrebaeck, CAK., and Wingren C.,  Proteomics – Clinical Applications. 2012, 6, 486-496.

Identification of serum biomarker signatures associated with pancreatic cancer.

Wingren C, Sandström A, Segersvärd R, Carlsson A, Andersson R, Löhr M, Borrebaeck CAK Cancer Research, 2012, 72, 2481-2490.

Detection of pancreatic cancer using antibody microarray-based serum protein profiling.

Ingvarsson, J., Wingren, C., Carlsson, A., Ellmark, P., Wahren, B., Engström, G., Harmenberg, U., Krogh, M., Peterson, C., and Borrebaeck, C.A.K., Proteomics. 2008, 8, 2211-2219